Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

3480 Press Releases
DateTitleCompany
29 Aug 15 RaySearch awarded treatment planning installation at premier cancer center in the US RayStation,
Published by
Pharmiweb.com
29 Aug 15 The University of Florida Health Proton Therapy Institute selects RayStation RayStation,
Published by
Pharmiweb.com
29 Aug 15 Gustave Roussy chooses RayStation as its main treatment planning system RayStation,
Published by
Pharmiweb.com
29 Aug 15 University of North Carolina selects RayStation as its new network-wide radiation therapy treatment planning system The University of North Carolina,
Published by
Pharmiweb.com
29 Aug 15 uniQure Announces Financial Results for Second Quarter 2015 uniQure,
Published by
Pharmiweb.com
29 Aug 15 Generex Announces Issuance of Buccal Insulin White Paper Generex,
Published by
Pharmiweb.com
29 Aug 15 Amarantus Moves Annual Meeting Date Forward to September 2, 2015 Amarantus,
Published by
Pharmiweb.com
29 Aug 15 Aegis Therapeutics Awarded Third Patent for Metered Nasal Spray Parathyroid Hormone (PTH) Peptide Drug Formulations Aegis Therapeutics,
Published by
Pharmiweb.com
29 Aug 15 RedHill Biopharma Receives Notice of Allowance for New Israeli Patent Covering RHB-104 for the Treatment of Crohn's Disease RedHill Biopharma,
Published by
Pharmiweb.com
29 Aug 15 Dow AgroSciences and ICS-CAAS Partner to Accelerate Rice Research and Product Development in China Dow AgroSciences,
Published by
Pharmiweb.com
29 Aug 15 Dow AgroSciences Opens New Seeds R&D Site in Huron, South Dakota Dow AgroSciences,
Published by
Pharmiweb.com
29 Aug 15 Takeda Announces Appointment of New Senior Leadership Takeda,
Published by
Pharmiweb.com
29 Aug 15 Takeda and Nanotherapeutics Announce Agreement to Expand Takeda's Commercialization and Technology Access Rights in Support of Influenza and Other Vaccine Programs Takeda,
Published by
Pharmiweb.com
29 Aug 15 Minerva Granted Worldwide License to Sendai Virus Technology for Stem Cell Generation Minerva,
Published by
Pharmiweb.com
29 Aug 15 Allied Minds Announces Half-Yearly Results Allied-Bristol Life Sciences,
Published by
Pharmiweb.com
29 Aug 15 Allied-Bristol Life Sciences Licenses Platform Technology from Yale University Allied-Bristol Life Sciences,
Published by
Pharmiweb.com
29 Aug 15 AGTC Announces Achievement of XLRS Patient Enrollment Milestone in Biogen Collaboration AGTC,
Published by
Pharmiweb.com
29 Aug 15 QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities QB3@953,
Published by
Pharmiweb.com
29 Aug 15 Neogen acquires U.K.-based Lab M Holdings Neogen,
Published by
Pharmiweb.com
29 Aug 15 InSite Vision and QLT Amend Merger Agreement InSite Vision,
Published by
Pharmiweb.com
29 Aug 15 Two New Studies Supported by The ALS Association Highlight Discovery Around Most Common ALS Gene Mutation ALS Association,
Published by
Pharmiweb.com
29 Aug 15 Adocia And Eli Lilly (LLY) Initiate New Phase 1b Study Of Repeated Administration Of Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes Adocia,
Published by
Pharmiweb.com
29 Aug 15 Threshold Pharmaceuticals Initiates Phase 2 Clinical Trial of Tarloxotinib Bromide* (TH-4000) in Patients With Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck or Skin Threshold Pharmaceuticals,
Published by
Pharmiweb.com
29 Aug 15 Analytik Jena Introduces the World’s First Hepatitis D Virus Test with CE-IVD Certification Applying WHO Standard to the Market Analytik Jena,
Published by
Pharmiweb.com
29 Aug 15 Exelixis Announces First Regulatory Approval of Cobimetinib in Switzerland Exelixis,
Published by
Pharmiweb.com
29 Aug 15 Data Published in The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses in Heavily Pre-treated Relapsed or Refractory Multiple Myeloma Patients Genmab,
Published by
Pharmiweb.com
29 Aug 15 Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil Gilead Sciences,
Published by
Pharmiweb.com
29 Aug 15 Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 Portage Biohaven,
Published by
Pharmiweb.com
29 Aug 15 Janssen Research & Development Release: Data Published In The New England Journal of Medicine Show Single-Agent Daratumumab Demonstrated A 36 Percent Overall Response Rate And Tolerable Safety Profile In Heavily Pre-Treated Multiple Myeloma Patients Janssen Research,
Published by
Pharmiweb.com
29 Aug 15 Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation Symbiomix Therapeutics,
Published by
Pharmiweb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.